Condition
Ovarian Carcinosarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Ovarian Carcinosarcoma clinical trials that are recruiting, at sites in 6 countries (most in United States (4), France (1), Italy (1)). By phase: Phase 2/3 (1), Phase 2 (1), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Ovarian Carcinosarcoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression | — | Arcadia, California and 10 other locations | Recruiting | Aug 3, 2026 |
| Testing Olaparib with or without Bevacizumab for Ovarian Cancer Treatment | Phase 3 | Birmingham, Alabama and 708 other locations | Recruiting | Aug 30, 2024 |
| Testing VLS-1488 for advanced cancers | Phase 1/2 | Los Angeles, California and 13 other locations | Recruiting | Jun 15, 2023 |
| Combining APL-2 with Pembrolizumab and Bevacizumab for Recurrent Ovarian Cancer | Phase 2 | Buffalo, New York | Recruiting | Jun 9, 2021 |
| Niraparib alone or with dostarlimab for recurrent ovarian or uterine carcinosarcoma | Phase 2/3 | Angers and 35 other locations | Recruiting | Aug 29, 2018 |
All recruiting trials (5)
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Testing Olaparib with or without Bevacizumab for Ovarian Cancer Treatment
This study is testing if a new cancer treatment called olaparib, alone or with another drug called bevacizumab, can help women with advanced ovarian cancer live longer without their cancer getting worse.
-
Testing VLS-1488 for advanced cancers
This study is testing a new oral medication called VLS-1488 to see if it is safe and effective for people with advanced solid tumors.
-
Combining APL-2 with Pembrolizumab and Bevacizumab for Recurrent Ovarian Cancer
This study is testing if a new treatment combining APL-2 with pembrolizumab and bevacizumab can help people with recurrent ovarian cancer feel better and live longer compared to just using bevacizumab alone.
-
Niraparib alone or with dostarlimab for recurrent ovarian or uterine carcinosarcoma
This trial tests whether the oral drug niraparib, alone or combined with the immunotherapy dostarlimab, helps people with recurrent or metastatic ovarian or uterine carcinosarcoma.
Related topics
Quick answers
How many Ovarian Carcinosarcoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (4 trials), France (1 trial), Italy (1 trial), Spain (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 2: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.